These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3705811)

  • 41. Measles vaccination. VIII. The occurrence of antibodies against virus envelope components after immunization with inactivated vaccine. Effects of revaccination with live measles vaccine.
    Norrby E; Lagercrantz R
    Acta Paediatr Scand; 1976 Mar; 65(2):171-6. PubMed ID: 1258633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measles immunity in children vaccinated before one year of age.
    Schluederberg A; Lamm SH; Landrigan PJ; Black FL
    Am J Epidemiol; 1973 Jun; 97(6):402-9. PubMed ID: 4713935
    [No Abstract]   [Full Text] [Related]  

  • 43. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The characteristics of the synthesis of specific antihemagglutinins and antihemolysins in subjects inoculated with live measles vaccine in different climatic and geographical areas].
    Novitskiĭ IA; Tikhonova NT; Mamaeva TA; Dubov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):64-8. PubMed ID: 7941872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [An increase in the effectiveness of the vaccinal prophylaxis of measles].
    Siniak KM
    Vrach Delo; 1989 Nov; (11):1-5. PubMed ID: 2609566
    [No Abstract]   [Full Text] [Related]  

  • 47. Measles in children previously vaccinated against measles.
    Lerman SJ; Gold E
    JAMA; 1971 May; 216(8):1311-4. PubMed ID: 4102807
    [No Abstract]   [Full Text] [Related]  

  • 48. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measles immunity and response to revaccination among secondary school children in Cumbria.
    Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
    Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.
    Paunio M; Hedman K; Davidkin I; Valle M; Heinonen OP; Leinikki P; Salmi A; Peltola H
    Epidemiol Infect; 2000 Apr; 124(2):263-71. PubMed ID: 10813152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Studies on the persistence of immunity 15 years after revaccination with measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):392-5. PubMed ID: 2598096
    [No Abstract]   [Full Text] [Related]  

  • 54. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
    Liashenko VA; Krasnova VP; Youminova NV
    Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 56. Measles reimmunization in children seronegative after initial immunization.
    Poland GA; Jacobson RM; Thampy AM; Colbourne SA; Wollan PC; Lipsky JJ; Jacobsen SJ
    JAMA; 1997 Apr; 277(14):1156-8. PubMed ID: 9087472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.
    Whittle HC; Campbell H; Rahman S; Armstrong JR
    Lancet; 1990 Oct; 336(8722):1046-8. PubMed ID: 1977029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study on the immunization effect of measles vaccine by capture-EIA].
    Fang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):297-9. PubMed ID: 1300252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Measles epidemiology and the status of specific immunity in Novgorod Province during a mass immunization].
    Golubeva LI; Brantseva IV
    Tr Inst Im Pastera; 1985; 62():68-72. PubMed ID: 2954277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.